INTRODUCTION
Human immunodeficiency virus 1 (HIV-1) is the etiological agent of AIDS (acquired immunodeficiency syndrome) [1, 2] . The virus typically infects cells expressing the CD4 receptor [3, 4] . However, the virus is able to express its gene products even when transfected into cells that do not express the CD4 receptor, such as HeLa cells [5] . These observations imply that HIV is able to use host-cell transcriptional factors common to many cell types for its transcriptional regulation.
Deletion analysis of chloramphenicol acetyltransferase constructs (CAT assays) and DNAase footprinting assays of the HIV long terminal repeat (LTR) have revealed that at least five distinct regions are involved in the regulation of the transcription of the viral genes by interacting with cellular proteins [6] . Among these regions, a negative regulatory element (-173 to -159) and a positive regulatory element or enhancer (-104 to -78) have been identified [6] [7] [8] . The enhancer element is composed of two direct repeats of the sequence GGGACTTTCC [8, 9] . This sequence is identical with the K-light-chain-enhancer sequence or KB site, except that the sequence is not repeated [10] . The K-light-chainenhancer site is bound by a constitutively expressed protein, NF-KB, in mature B-cells. In pre-B-cells, NF-KB is induced by lipopolysaccharide [10] . NF-KB was recently purified from bovine spleen and shown to be a 42-44 kDa protein [1 1] . Furthermore, Nabel & Baltimore [9] showed that phorbol ester plus mitogen induced a protein that is specific to a human T-cell line (Jurkat) and binds to the HIV enhancer element. In their original report those authors postulated that the HIV-enhancer-specific binding protein in Jurkat cells is identical with B-cell NF-KB. Stimulation of Jurkat cells with lectin and phorbol esters induces the expression of both interleukin-2 (IL2) and its receptor a-subunit (IL2Ra). Purified NF-cB binds to both IL2 and IL2Ra enhancer domains [11] . However, another protein, HIVEN 86A, characterized in the same cells, was able to bind both the HIV enhancer element [12] and the IL2Ra enhancer [13] . Two other groups have purified HIV enhancer-binding proteins from phorbol-ester-treated HeLa cells [14] and the Namalwa B-cell line [15] . The protein purified from HeLa-cell extracts had an apparent Mr of 55000-60000, whereas the Mr of the protein from the Namalwa cells was reported to be 51000. Therefore both lymphoid and non-lymphoid cells express Two synthetic double-stranded oligonucleotides were used as probes for detection of the HIV enhancerbinding proteins. A 31-mer oligonucleotide or 'Tandemr', which contains the two direct repeats of the HIV enhancer sequence from the position -107 to -80 [6] (5'-ACAAGGGACTTTCCGCTGGGGACTTTCCAGG-3'), and a 16-mer oligonucleotide or 'Mono', containing only the 5' site from the position -107 to -92. Two other double-stranded oligonucleotides were also synthesized: a 16-mer containing the sequence of the IL2Ra promoter from the position -270 to -255 [17] (5'-GCAGGGAATCTCCCT-3') and a 33-mer oligonucleotide containing the cyclic AMP-responsive element (CRE) of the human pro-enkephalin from the position -108 to -76 [18] (5'-GGGCTGGCGTAGG-GCCTGCGTCAGCTGCAGCCC-3'). In the u.v. crosslinking experiments, an oligonucleotide containing the API/c-Jun binding site [19] was also used (5'-GATCCGGCTGACTCATG-3'). The oligonucleotide probes were end-labelled with phage-T4 kinase.
The gel-retardation assays were performed as follows: and further fractionated by affinity chromatography by using a trimeric repeat of the mono oligonucleotide (a 48-mer) covalently bound to a CNBr-activated Sepharose (Pharmacia) as described in [21] . The density of the oligonucleotide was approx. 140,ug/g of dry gel. The proteins were loaded at a rate of 0.5 ml/min. The unbound material was washed out with 2.5 column volumes of the A50 buffer. The bound proteins were eluted in 2 ml fractions by a discontinuous gradient of KCI (0.2, 0.5 and 1.0 M) in the presence of a 0.05 % Nonidet P40. After dialysing the fractions against the A50 buffer, the DNA-binding activity was assayed by the DNA gel-retardation assay. The active dialysed fractions were pooled, and the affinity chromatography was repeated a second time.
U.v. cross-linking
The probe used for the u.v. cross-linking experiment was prepared by following the instructions of the manufacturer (Boehringer-Mannheim); the Tandem singlestranded oligonucleotide was added to the BoehringerMannheim random primed DNA labelling kit mixture. A 100 1tCi portion of [32P]dCTP and 0.5 nmol of BrdUTP were added.to the reaction mixture. After 30 min incubation at 37°C, 0.5 nmol of dCTP were added. The labelled probe was purified from the free nucleotides by two passages through Sepharose G-25. Its radioactivity averaged 500000 c.p.m./,ul. The u.v. cross-linking of proteins with the 32P-labelled BrdUr-substituted Tandem oligonucleotide was performed as described [22] , except that after irradiation the samples were immediately boiled in 2.5% SDS/1 mM-EDTA/20 Qo glycerol/i 00 2-mercaptoethanol. The electrophoretic separation was performed on 10 %-polyacrylamide gels as described by Porzio & Pearson [23] .
RESULTS

Induction of HIV enhancer-binding proteins
We first examined the capacity of proteins extracted from Jurkat cells to bind to the synthetic oligonucleotides which represented either a single copy (Mono) or two copies (Tandem) of the KB site of the HIV enhancer domain. Both oligonucleotides formed two protein-DNA complexes, Cl and C2, with distinct electrophoretic mobilities (Fig. 1) . The Cl complex was greatly increased by the stimulation of Jurkat cells by PMA and PHA. This is in agreement with previously described induction of HIV enhancer-binding proteins in Jurkat cells by Nabel & Baltimore [9] . In their study the radiolabelled probe used was much larger (90 bp (Fig. 1, lane 2) , whereas Mg2+ and Ca2+ did not (Fig. 2, lanes 5 and 8) . At higher Zn2+ concentrations (2 and 5 mM) Cl complex was dissociated, whereas the C2 complex was greatly augmented (Fig. 2, lanes 3  and 4) . At the same concentrations Ca2+ had no effect on the stability of either Cl or C2, whereas Mg2+ (5 mM) had a dissociating effect on the Cl complex without affecting the C2 complex (Fig. 2) . EDTA (10 mM) had no effect on the Cl complex, favoured partial dissociation of C2 complex (Fig. 2, lane 11) and efficiently abolished the dissociating effect of Mg2+ on the Cl complex (results not shown). Cl and C2 also differed in their sensitivity to high ionic strength, since Cl was more easily dissociated by 0.4 M-KCl than was C2 (Fig. 2, lane 12) . Therefore it is possible to favour selectively the binding of either Cl or C2 proteins to the HIV enhancer by manipulating the ionic composition of the reaction medium. Isolation of the Cl-complex protein In order to isolate the inducible Cl-complex proteins we performed the fractionation and oligonucleotidebinding assays in the absence of Mg2+ ions. The first chromatographic fractionation was performed with DEAE-5PW h.p.l.c. About 70 % of the loaded proteins did bind to the column (Fig. 3b) . The oligonucleotidebinding activity was found exclusively in the KCl-eluted fractions, suggesting that all the active proteins bound to the DEAE (Fig. 3a) C2, C2- Cl proteins were eluted at higher salt concentrations (0.22-0.25 M-KCI) (pool 1). A third pool (pool 3, fractions 30-33), contained both the Cl and C2 proteins eluted with 0.25-0.3 M-KCI. The C2 and C2' proteins either comigrated in the unfractionated extract or one of the two activities was generated by the fractionation procedure. Indeed, the fractionation could possibly have eliminated an inhibitor of one of the two binding activities.
After pooling the fractions containing the same binding activities, we analysed the specificity of their binding to the 32P-labelled Mono probe by competition with a 100-fold excess of unlabelled oligonucleotides (Fig. 4) 10 and 15) . To check the selectivity of binding of the three pools to the KB site, we used the CRE oligonucleotide as a competitor, since it contains a binding site for the cyclic AMP-induced nuclear proteins. The CRE oligonucleotide has no sequence similarity with the KB site (see the Experimental section). CRE probes did not compete for binding Cl and C2', but partially inhibited the binding of C2 (lanes 4, 9 and 14). These results indicate that C1 and C2' binding activities are specific for binding the HIV enhancer probes, but the C2 protein complex is not. The IL2Ra enhancer probe sequence is similar to, but not identical with, the KB site, which may explain why it appears to have a lower affinity for C1 and C2' binding activities (see also Fig. 6 below) . The sensitivity to Mg2" of fractionated Cl binding activity remained unchanged compared with the Cl binding activity from the initial extract. C2' complex was also inhibited by 5 the major induced proteins, was further purified by twostep affinity chromatography. The activity was eluted with 0.5 M-KCl and co-migrated with the Cl complex from the unfractionated pool 1 (Fig. 5) . A single migrating activity was generated by this chromatographic step; however, recovery after this step was superior to that obtained after DEAE h.p.l.c. (see Table 1 ). One possible explanation for this enhanced yield is the elimination of an inhibitor during this chromatographic step. Similar increases in activity were recently described during the purification of the NF-KB from bovine spleen [11] (see the Discussion section). The overall enrichment after this first affinity chromatography was 800-fold (see Table 1 ). The active fractions were pooled and refractionated by the same chromatographic procedure. Cl activity was eluted in two fractions with 0.5 M-KCI (results not shown). This second step resulted in a 1000-fold overall purification (Table 1) , but recovery decreased from 70 to 43 % of the initial activity. C2' binding activity from pool 2 was also analysed by affinity chromatography. However, the recovery of activity after this step was too low to allow further analysis.
Molecular-mass analysis of Cl proteins by u.v. crosslinking
To determine the molecular mass of the Cl proteins, we loaded the initial extract directly on the affinity- (Fig. 6, lane 1) . The addition of 500-fold molar excess of unlabelled competitors differentially affected the two proteins complexed with the oligonucleotide probe. Unlabelled Tandem probe completely inhibited the labelling of p47 and only partially inhibited p60 complex, whereas two sequence-unrelated oligonucleotides, corresponding to the CRE and API binding sites, did not inhibit the labelling of p47, although they partially inhibited the labelling of the p60 (Fig. 6, lanes 3 and 5) . The IL2Ra enhancer probe partially inhibited the labelling of both p47 and p60 (Fig. 6, lane 4) . When u.v. cross-linking was performed with the initial extract, many proteins were labelled, including p47 and p60 (results not shown). We also performed u.v. cross-linking of 1000-fold-purified Cl binding activity by both the DEAE h.p.l.c. and the two affinity-chromatographic steps (see Table 1 ). A labelled protein migrated with an apparent molecular mass of 40 kDa. This difference in molecular mass is probably due to partial proteolysis occurring during the three-step purification. We deduce from the u.v.-crosslinking data that the protein responsible for Cl complexformation has a molecular mass of 47 kDa.
DISCUSSION
In the present study we (Table 2) . It is not clear whether the protein(s) responsible for C2' electrophoretic mobility are related to p47. C2' could be a proteolytic product of p47 or it may be a modified form of p47 (perhaps due to phosphorylation of CI).
The induction of active NF-KB in T-cells has been attributed to dissociation from a cytoplasmic inhibitor, IKB [28] , which allowed the translocation of NF-KB into the nucleus and subsequent activation of transcription of IL2 and IL2Ra genes. P47 also might be associated with an inhibitor, since its fractionation from the whole-cell extract by affinity chromatography increased binding activity (see the Results section, in particular Table 1 [12] , EBP-1, a 55-60 kDa protein, was purified from phorbol-ester-treated HeLa cells [14] , and H2TF1, a 48 kDa protein, was purified from murine thymoma cells [20] . NF-KB is constitutively expressed only in mature B-cells, where it regulates the transcription of K light chain, but it is also inducible in T-cells, where it might regulate transcription of IL2 and IL2Ra [11, 13, 26, 27] . At present we have not identified with certainty a cellular enhancer for p47, since it binds IL2Ra enhancer probe with much lower affinity than HIV-1 enhancer probes, at least in the assays in vitro used in the present study.
In our experiment we found that p47 differs in size from the previously described Jurkat-cell HIV enhancerbinding protein, HIVEN 86A [12] , as well as from the HeLa-cell HIV enhancer-binding protein, EBP-1 [14] . However, its size is comparable with NF-KB isolated either from bovine spleen cells (42-44 kDa) [11] or a human B-cell line (51 kDa) [15] , as well as with the 48 kDa H2TF1 or KBFl [20] . It is not clear whether p47, NF-KB and H2TF1 are products of the same gene with different post-translational modifications or whether they result from the expression of different genes. It is not unusual for several different proteins to recognize the same DNA sequence. Indeed, the mammalian transcription factor cJun/API, the yeast GCN4 and several other mammalian and yeast proteins all bind to the same consensus sequence ATGA(C/G)TCAT (see [25] for review). H2TF1 and NF-KB differ by their KB-site-binding characteristics [11, 29] . However, the relation between p47, NF-KB, H2TF1, EDBP-l and HIVEN 86 A is not clear. In spite of several described differences such as molecular mass, affinities for KB site and modulation of the binding to KB site by nucleotides, NF-KB, H2TFl and p47 could be structurally related. The specificity of their transcriptional activity could be due to different post-translational modifications or to interaction with other, cell or signal, specific proteins.
